BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36193777)

  • 1. Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
    Zhang Z; Chen Q; Huang C; Rao D; Sang C; Zhu S; Gu L; Xie C; Tang Z; Xu X
    Mol Carcinog; 2022 Dec; 61(12):1161-1176. PubMed ID: 36193777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathway.
    Yu B; Zhou Y; He J
    Cell Cycle; 2023 Jun; 22(12):1496-1513. PubMed ID: 37245083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
    Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
    J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the functional role of SETD6 in lung adenocarcinoma.
    Xu J; Zhou H; Luo Z; Chen J; Liu M
    BMC Cancer; 2023 Jan; 23(1):18. PubMed ID: 36604642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Oxidative Stress Reduces NRF2 SUMOylation to Promote
    Xu J; Guo H; Xing Z; Zhang W; He J; Cheng J; Cai R
    Oxid Med Cell Longev; 2020; 2020():6240125. PubMed ID: 33299528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma.
    Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B
    Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features].
    Xiao Y; Zhu X; Gu Y; Chen S; Liang L; Cao B
    Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):241-250. PubMed ID: 29587953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1.
    Huang Q; Guo H; Wang S; Ma Y; Chen H; Li H; Li J; Li X; Yang F; Qiu M; Zhao S; Wang J
    Cell Death Dis; 2020 Dec; 11(12):1031. PubMed ID: 33268793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
    Cardnell RJ; Behrens C; Diao L; Fan Y; Tang X; Tong P; Minna JD; Mills GB; Heymach JV; Wistuba II; Wang J; Byers LA
    Clin Cancer Res; 2015 Aug; 21(15):3480-91. PubMed ID: 25878335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of nuclear factor (erythroid-derived 2)-like 2 protein level in the human colorectal adenocarcinoma cell line DLD-1 by a heterocyclic organobismuth(III) compound: Effect of organobismuth(III) compound on NRF2 signaling.
    Iuchi K; Tasaki Y; Shirai S; Hisatomi H
    Biomed Pharmacother; 2020 May; 125():109928. PubMed ID: 32004978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
    Du J; Zhang G; Qiu H; Yu H; Yuan W
    Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung.
    Zhang B; Ma Z; Tan B; Lin N
    Expert Opin Ther Targets; 2019 Mar; 23(3):241-250. PubMed ID: 30556750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox
    Wei XW; Lu C; Zhang YC; Fan X; Xu CR; Chen ZH; Wang F; Yang XR; Deng JY; Yang MY; Gou Q; Mei SQ; Luo WC; Zhong RW; Zhong WZ; Yang JJ; Zhang XC; Tu HY; Wu YL; Zhou Q
    Oncoimmunology; 2024; 13(1):2340154. PubMed ID: 38601319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.
    Sakurai T; Isogaya K; Sakai S; Morikawa M; Morishita Y; Ehata S; Miyazono K; Koinuma D
    Oncogene; 2016 Sep; 35(38):5000-9. PubMed ID: 26923328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
    Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
    Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Significance of Keap1 mRNA Expression for Lung Cancer Based on Microarray and Clinical Information from Oncomine Database.
    Liu GY; Zhang W; Chen XC; Wu WJ; Wan SQ
    Curr Med Sci; 2021 Jun; 41(3):597-609. PubMed ID: 34169426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma.
    Hu S; Yuan Y; Yan R; Xie H; Cai R; Xu J
    Biochem Biophys Res Commun; 2024 May; 708():149798. PubMed ID: 38518721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circABCC4 regulates lung adenocarcinoma progression via miR-3186-3p/TNRC6B axis.
    Liu M; Wang P; Sui X; Ding F; Liu L; Gao Z; Cheng Z
    J Cell Biochem; 2020 Oct; 121(10):4226-4238. PubMed ID: 31960988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.